These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 37892091)
1. Pancreatic Ductal Adenocarcinoma: The Characteristics of Contrast-Enhanced Ultrasound Are Correlated with the Hypoxic Microenvironment. Wang L; Li M; Dong T; Li Y; Yin C; Nie F Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892091 [TBL] [Abstract][Full Text] [Related]
2. High expression of hypoxia-inducible factor 1-alpha predicts poor prognosis in pancreatic ductal adenocarcinoma: a meta-analysis and database validation protocol. Zoa A; Yang Y; Huang W; Yang J; Wang J; Wang H; Dong M; Tian Y Transl Cancer Res; 2022 Sep; 11(9):3080-3091. PubMed ID: 36237265 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic ductal adenocarcinoma: CEUS characteristics are correlated with pathological findings and help predict early recurrence after resection. Wang L; Wang G; Wang P; Nie F J Clin Ultrasound; 2024; 52(3):230-240. PubMed ID: 38018362 [TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: correlation of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters with hypoxia-inducible factor 1α expression and tumor grade/stage. Liu L; Hu L; Zeng Q; Peng D; Chen Z; Huang C; Liu Z; Wen Q; Zou F; Yan L Ann Palliat Med; 2021 Feb; 10(2):2238-2253. PubMed ID: 33725777 [TBL] [Abstract][Full Text] [Related]
5. IL-37/ STAT3/ HIF-1α negative feedback signaling drives gemcitabine resistance in pancreatic cancer. Zhao T; Jin F; Xiao D; Wang H; Huang C; Wang X; Gao S; Liu J; Yang S; Hao J Theranostics; 2020; 10(9):4088-4100. PubMed ID: 32226541 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of the combination of HIF‑1α and GLUT1 in patients with oesophageal squamous cell carcinoma. Yi H; Han Y; Li Q; Lin R; Zhang J; Yang Y; Wang X; Zhang L Oncol Lett; 2023 Sep; 26(3):404. PubMed ID: 37600334 [TBL] [Abstract][Full Text] [Related]
7. Expression of hypoxia-inducible factor 1α, glucose transporter 1, and hexokinase 2 in primary central nervous system lymphoma and the correlation with the biological behaviors. Shen N; Wang Y; Sun X; Bai X; He J; Cui Q; Qian J; Zhu H; Chen Y; Xing R; Liu Q; Wu Y; Li J; Lai W; Sun S; Ji N; Liu Y Brain Behav; 2020 Aug; 10(8):e01718. PubMed ID: 32533646 [TBL] [Abstract][Full Text] [Related]
8. Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma. Qiu YJ; Zhao GC; Shi SN; Zuo D; Zhang Q; Dong Y; Lou WH; Wang WP Clin Hemorheol Microcirc; 2022; 81(2):149-161. PubMed ID: 35253737 [TBL] [Abstract][Full Text] [Related]
9. Nonhypovascular pancreatic ductal adenocarcinomas: CEUS imaging findings and differentiation from other types of solid pancreatic lesions. Wang L; Nie F; Dong T; Yin C; Li M; Li Y Clin Hemorheol Microcirc; 2022; 81(2):163-176. PubMed ID: 35253738 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas. Zhuang H; Wang S; Chen B; Zhang Z; Ma Z; Li Z; Liu C; Zhou Z; Gong Y; Huang S; Hou B; Chen Y; Zhang C Front Immunol; 2021; 12():790661. PubMed ID: 34925373 [TBL] [Abstract][Full Text] [Related]
11. [Correlations of expressions of Glut1 and HIF-1alpha to cellular proliferation of colorectal adenocarcinoma]. Zhou YL; Deng CS Ai Zheng; 2005 Jun; 24(6):685-9. PubMed ID: 15946479 [TBL] [Abstract][Full Text] [Related]
13. SCF, regulated by HIF-1α, promotes pancreatic ductal adenocarcinoma cell progression. Gao C; Li S; Zhao T; Chen J; Ren H; Zhang H; Wang X; Lang M; Liu J; Gao S; Zhao X; Sheng J; Yuan Z; Hao J PLoS One; 2015; 10(3):e0121338. PubMed ID: 25799412 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin. Zhao X; Gao S; Ren H; Sun W; Zhang H; Sun J; Yang S; Hao J Cancer Res; 2014 May; 74(9):2455-64. PubMed ID: 24599125 [TBL] [Abstract][Full Text] [Related]
15. miR-212 regulated by HIF-1α promotes the progression of pancreatic cancer. Yue H; Liu L; Song Z Exp Ther Med; 2019 Mar; 17(3):2359-2365. PubMed ID: 30867721 [TBL] [Abstract][Full Text] [Related]
16. How does hypoxia inducible factor-1α participate in enhancing the glycolysis activity in cervical cancer? Cheng Y; Chen G; Hong L; Zhou L; Hu M; Li B; Huang J; Xia L; Li C Ann Diagn Pathol; 2013 Jun; 17(3):305-11. PubMed ID: 23375385 [TBL] [Abstract][Full Text] [Related]
17. Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry. Kim BW; Cho H; Chung JY; Conway C; Ylaya K; Kim JH; Hewitt SM J Transl Med; 2013 Aug; 11():185. PubMed ID: 23927384 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of PHD3 represses the HIF-1 signaling pathway and contributes to poor neovascularization in pancreatic ductal adenocarcinoma. Tanaka T; Li TS; Urata Y; Goto S; Ono Y; Kawakatsu M; Matsushima H; Hirabaru M; Adachi T; Kitasato A; Takatsuki M; Kuroki T; Eguchi S J Gastroenterol; 2015 Sep; 50(9):975-83. PubMed ID: 25542265 [TBL] [Abstract][Full Text] [Related]
19. Evaluations of the combined use of blood- and tissue-based protein biomarkers for pancreatic cancer. Wiewiora M; Jopek J; Świętochowska E; Grynkiewicz M; Piecuch J Clin Hemorheol Microcirc; 2024; 86(3):383-393. PubMed ID: 37955083 [TBL] [Abstract][Full Text] [Related]